olprinone has been researched along with Asthma, Bronchial in 4 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " In order to examine the usefulness of inhaled PDE3 inhibitors in the treatment of asthma, we investigated the bronchodilator effect of inhaled olprinone, a newly developed PDE3 inhibitor, in nine asthmatic patients." | 9.09 | Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients. ( Fujimura, M; Hashimoto, T; Hirose, T; Ishiura, Y; Kamio, Y; Matsuda, T; Myou, S; Tachibana, H, 1999) |
| "In 12 patients with mild stable asthma, we compared the acute bronchodilator effects of the following two drugs, alone and together using a double-blind crossover design: intravenous administration of olprinone, 30 micro g min-1; aminophylline, 2." | 7.72 | Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients. ( Fujimura, M; Hashimoto, T; Hirose, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Tachibana, H; Watanabe, K, 2003) |
| " We report a successful use of olprinone, a PDEIII inhibitor, for treatment of an asthmatic attack." | 7.71 | Use of olprinone, a phosphodiesterase III inhibitor, in an asthmatic patient. ( Hashimoto, H; Hirota, K; Ishihara, H; Kabara, S; Matsuki, A, 2001) |
| " In order to examine the usefulness of inhaled PDE3 inhibitors in the treatment of asthma, we investigated the bronchodilator effect of inhaled olprinone, a newly developed PDE3 inhibitor, in nine asthmatic patients." | 5.09 | Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients. ( Fujimura, M; Hashimoto, T; Hirose, T; Ishiura, Y; Kamio, Y; Matsuda, T; Myou, S; Tachibana, H, 1999) |
| "In 12 patients with mild stable asthma, we compared the acute bronchodilator effects of the following two drugs, alone and together using a double-blind crossover design: intravenous administration of olprinone, 30 micro g min-1; aminophylline, 2." | 3.72 | Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients. ( Fujimura, M; Hashimoto, T; Hirose, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Tachibana, H; Watanabe, K, 2003) |
| " We report a successful use of olprinone, a PDEIII inhibitor, for treatment of an asthmatic attack." | 3.71 | Use of olprinone, a phosphodiesterase III inhibitor, in an asthmatic patient. ( Hashimoto, H; Hirota, K; Ishihara, H; Kabara, S; Matsuki, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myou, S | 3 |
| Fujimura, M | 3 |
| Kamio, Y | 2 |
| Hirose, T | 3 |
| Kita, T | 1 |
| Tachibana, H | 3 |
| Ishiura, Y | 2 |
| Watanabe, K | 1 |
| Hashimoto, T | 2 |
| Nakao, S | 2 |
| Matsuda, T | 1 |
| Kurashima, K | 1 |
| Hirota, K | 1 |
| Kabara, S | 1 |
| Hashimoto, H | 1 |
| Ishihara, H | 1 |
| Matsuki, A | 1 |
1 trial available for olprinone and Asthma, Bronchial
| Article | Year |
|---|---|
Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients.
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Analysis of Variance; Asthma; Bronchodilator Age | 1999 |
3 other studies available for olprinone and Asthma, Bronchial
| Article | Year |
|---|---|
Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aminophylline; Anti-Asthmatic Agents; Asthma; Bronchodil | 2003 |
Effect of aerosolized administration of KF19514, a phosphodiesterase 4 inhibitor, on bronchial hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea-pigs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Aerosols; Animals; Antigens; Asthma | 2000 |
Use of olprinone, a phosphodiesterase III inhibitor, in an asthmatic patient.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Airway Resistance; Anti-Asthmatic Agents; Asthma; Bronch | 2001 |